RAB10 and Parkinson disease: Finally, we showed that missense variants in LRRK2 associated with reduced risk for PD and Crohn’s disease lead to lower levels of Rab10 phosphorylation, suggesting that these variants may lower disease risk by reducing the activity of the LRRK2 signaling pathway.